Ligand Pharmaceuticals, Inc.

Ligand Pharmaceuticals Inc. is a biopharmaceutical company that specializes in developing technologies and assets that aid in the discovery process and production of vital therapeutic drugs. The company's primary function is to support pharmaceutical innovation through its proprietary technology platforms, including Captisol, a chemically modified cyclodextrin used to improve the solubility and stability of drugs. Ligand operates in a diverse range of therapeutic areas, placing significant impact on industries related to oncology, inflammation, and infectious diseases, enhancing the effectiveness and delivery of treatments. Noteworthy for its business model, Ligand does not focus on manufacturing its own complete lines of medicines. Instead, it partners with a wide array of pharmaceutical companies, licensing its technologies to advance drug development, thus generating a stream of royalty and milestone revenues. Headquartered in San Diego, California, Ligand Pharmaceuticals plays a critical role in the drug development pipeline, enabling and expediting the creation of revolutionary medical solutions that save lives while maintaining a flexible and diversified portfolio of healthcare investments.